JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 9, 2003; DOI: 10.1124/jpet.103.052514


0022-3565/03/3072-535-543$20.00
JPET 307:535-543, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.052514v1
307/2/535    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, M.
Right arrow Articles by Alreja, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, M.
Right arrow Articles by Alreja, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

NEUROPHARMACOLOGY

Acetylcholinesterase Inhibitors Activate Septohippocampal GABAergic Neurons via Muscarinic but Not Nicotinic Receptors

Min Wu, Samuel S. Newton, Joshua B. Atkins, Changqing Xu, Ronald S. Duman, and Meenakshi Alreja

Departments of Psychiatry (M.W., S.S.N., J.B.A., R.S.D., M.A.) and Neurobiology (M.A.), Yale University School of Medicine and the Ribicoff Research Facilities, Connecticut Mental Health Center (C.X.), New Haven, Connecticut

Acetylcholinesterase (AChE) inhibitors, which increase synaptic levels of available acetylcholine (ACh) by preventing its degradation, are the most extensively prescribed drugs for the treatment of Alzheimer's disease. In animals, AChE inhibitors improve learning and memory, reverse scopolamine-induced amnesia, and produce hippocampal theta rhythm. The medial septum/diagonal band of Broca (MSDB), which maintains hippocampal theta rhythm and associated mnemonic functions via the septohippocampal pathway, is considered a critical locus for mediating the effects of AChE inhibitors. Using electrophysiological recordings and fluorescent labeling techniques to identify living septohippocampal neurons in rat brain slices, we report that AChE inhibitors, in the absence of exogenous ACh, produce a profound excitation in 94% of septohippocampal GABAergic neurons and an inhibition in 24% of septohippocampal cholinergic neurons. The inhibitory and excitatory effects of AChE inhibitors, presumably, occur due to accumulation of ACh that is released locally within the MSDB via axon collaterals of septohippocampal cholinergic neurons. The excitatory effects of AChE inhibitors on septohippocampal GABAergic neurons were blocked by muscarinic but not nicotinic receptor antagonists, especially by the M3 receptor antagonist, 4-diphenylacetoxy-N-methylpiperidine mustard, and not by M1 or M2/M4 muscarinic receptor antagonists. M3 muscarinic receptor mRNA colocalized with the calcium-binding protein, parvalbumin, a marker of septohippocampal GABAergic neurons. These findings may be useful in designing therapeutic strategies that do not depend on endogenous ACh and may therefore be effective in situations where AChE inhibitors cease to be effective, such as in progressive neurodegeneration.


Received for publication April 17, 2003
Accepted July 28, 2003.

Address correspondence to: Dr. Meenakshi Alreja, Department of Psychiatry, CMHC 335A, Yale University School of Medicine, 34 Park Street, New Haven, CT 06508. E-mail: Meenakshi.Alreja{at}yale.edu




This article has been cited by other articles:


Home page
J. Physiol.Home page
V. Varga, B. Hangya, K. Kranitz, A. Ludanyi, R. Zemankovics, I. Katona, R. Shigemoto, T. F. Freund, and Z. Borhegyi
The presence of pacemaker HCN channels identifies theta rhythmic GABAergic neurons in the medial septum
J. Physiol., August 15, 2008; 586(16): 3893 - 3915.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Z. Henderson, A. Boros, G. Janzso, A. J. Westwood, H. Monyer, and K. Halasy
Somato-dendritic nicotinic receptor responses recorded in vitro from the medial septal diagonal band complex of the rodent
J. Physiol., January 1, 2005; 562(1): 165 - 182.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. Xu, K. A Michelsen, M. Wu, E. Morozova, P. Panula, and M. Alreja
Histamine innervation and activation of septohippocampal GABAergic neurones: involvement of local ACh release
J. Physiol., December 15, 2004; 561(3): 657 - 670.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Wu, T. Hajszan, C. Xu, C. Leranth, and M. Alreja
Group I Metabotropic Glutamate Receptor Activation Produces a Direct Excitation of Identified Septohippocampal Cholinergic Neurons
J Neurophysiol, August 1, 2004; 92(2): 1216 - 1225.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Wu, L. Zaborszky, T. Hajszan, A. N. van den Pol, and M. Alreja
Hypocretin/Orexin Innervation and Excitation of Identified Septohippocampal Cholinergic Neurons
J. Neurosci., April 7, 2004; 24(14): 3527 - 3536.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.